Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Targeted Therapy in FLT3-ITD Positive Myeloid Sarcoma: Proof of Principle

Giovanni Grillo, MD, Elisa Zucchetti, MD, Barbara Forno, MD, Ivana Lotesoriere, MD, Elena Inzoli, MD, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5061.

https://doi.org/10.1182/blood.V130.Suppl_1.5061.5061

Published: 2017

Journal Articles

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Giovanni Grillo, MD, Ivana Lotesoriere, MD, Elisa Zucchetti, MD, Valentina Mancini, MD, Barbara Forno, MD, Giambattista Bertani, MD, Elena Inzoli, MD, Silvia Soriani, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5550.

https://doi.org/10.1182/blood.V130.Suppl_1.5550.5550

Published: 2017

Journal Articles

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Giovanni Grillo, MD, Elisa Zucchetti, MD, Elena Inzoli, MD, Valentina Mancini, MD, Barbara Forno, MD, Ivana Lotesoriere, MD, Giambattista Bertani, MD, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5553.

https://doi.org/10.1182/blood.V130.Suppl_1.5553.5553

Published: 2017

Journal Articles

Treosulfan-Based Myeloablative Conditioning for Autologous Stem Cell Transplantation In Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: Data of Feasibility and Efficacy In 10 Patients.

Massimo Bernardi, MD, Carlo Messina, MD, Michela Tassara, MD, Alessandro Crotta, MD, Fabio Giglio, MD, Andrea Assanelli, MD, Daniela Clerici, MD, Consuelo Corti, MD, Magda Marcatti, MD, Simona Malato, MD, Barbara Forno, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD

Blood (2010) 116 (21): 4596.

https://doi.org/10.1182/blood.V116.21.4596.4596

Published: 2010

Journal Articles

Implementation of An Alternative Donor Option Is Prerequisite for a Good Intention-to-Treat (ITT) In Patients In Need of Allogeneic Transplantation: Analysis of 410 Patients

Blood (2010) 116 (21): 2382.

https://doi.org/10.1182/blood.V116.21.2382.2382

Published: 2010

Journal Articles

Effect of Related and Unrelated Donor Haemopoietic Stem-Cell Transplantation on Outcome In Adults with High Risk Acute Leukemia: An Intention-to-Treat Analysis at a Single Center Institution

Blood (2010) 116 (21): 2385.

https://doi.org/10.1182/blood.V116.21.2385.2385

Published: 2010

Journal Articles

Allogeneic Transplantation with a Treosulfan-Fludarabine Conditioning Regimen Is Feasible and Effective in Elderly Patients with Refractory or Relapsed Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS); Preliminary Results From a Single Center Experience.

Massimo Bernardi, MD, Jacopo Peccatori, M.D., Michela Tassara, Alessandro Crotta, Carlo Messina, MD, Maria Teresa Lupo Stanghellini, MD, Barbara Forno, Stefania Girlanda, M.D., Andrea Assanelli, MD, Daniela Clerici, Sara Mastaglio, Annalisa Ruggeri, MD, Simona Malato, Fabio Giglio, MD, Consuelo Corti, M.D., Elena Guggiari, Matteo Giovanni Carrabba, Chiara Bonini, M.D., Fabio Ciceri, MD

Blood (2009) 114 (22): 4318.

https://doi.org/10.1182/blood.V114.22.4318.4318

Published: 2009

Journal Articles

WT1 Transcripts Is a Powerful Leukemia Marker to Predict Early Relapse After Allogeneic Haematopoietic Stem Cell Transplantation.

Blood (2009) 114 (22): 4488.

https://doi.org/10.1182/blood.V114.22.4488.4488

Published: 2009

Journal Articles

Quantitative Real-Time PCR Detection of Wilms' Tumor Gene (WT1) Transcript in Autologous Peripheral Blood Stem Cell (PBSC) Products Predict the Risk of Acute Myeloid Leukaemia (AML) Relapse After Autologous Transplantation (ASCT).

Carlo Messina, MD, Cristina Tresoldi, Alessandro Crotta, Michela Tassara, Simona Malato, Barbara Forno, Magda Marcatti, M.D., Jacopo Peccatori, M.D., Consuelo Corti, M.D., Katharina Fleischhauer, M.D., Claudio Bordignon, M.D., Fabio Ciceri, MD, Massimo Bernardi, M.D.

Blood (2009) 114 (22): 4690.

https://doi.org/10.1182/blood.V114.22.4690.4690

Published: 2009

Journal Articles

Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors.

Blood (2009) 114 (22): 203.

https://doi.org/10.1182/blood.V114.22.203.203

Published: 2009

Journal Articles

Genomic Loss of the Mismatched HLA Locus in Leukemia Is a Major Mechanism of in Vivo Escape from T Cell Immunosurveillance Following Haploidentical HSCT

Luca Vago, Serena Kimi Perna, Monica Zanussi, Benedetta Mazzi, Maria Teresa Lupo Stanghellini, Nicola Flavio Perrelli, Barbara Forno, Consuelo Corti, Massimo Bernardi, Jacopo Peccatori, Maurizio Ferrari, Silvano Rossini, Maria Grazia Roncarolo, Claudio Bordignon, Chiara Bonini, Fabio Ciceri, Katharina Fleischhauer

Blood (2008) 112 (11): 828.

https://doi.org/10.1182/blood.V112.11.828.828

Published: 2008

Journal Articles

Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation

Blood (2008) 112 (8): 3488–3499.

https://doi.org/10.1182/blood-2007-07-103325

Published: 2008

Journal Articles

Temporal, Quantitative and Functional Characteristics of Single-KIR Positive Alloreactive NK Cell Recovery Account for Impaired Graft Versus Leukemia Activity after Haploidentical HSCT.

Luca Vago, MD, Barbara Forno, MD, Elisabetta Zino, BS, Simona Di Terlizzi, BS, Maria T. Lupo Stanghellini, MD, Roberto Crocchiolo, MD, Serena K. Perna, MD, Attilio Bondanza, MD, PhD, Benedetta Mazzi, BS, Jacopo Peccatori, MD, Maria G. Roncarolo, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Katharina Fleischhauer, MD

Blood (2007) 110 (11): 3274.

https://doi.org/10.1182/blood.V110.11.3274.3274

Published: 2007

Journal Articles

Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT.

Luca Vago, MD, Elisabetta Zino, BS, Simona Di Terlizzi, BS, Barbara Forno, MS, Maria T. Lupo Stanghellini, MD, Serena K. Perna, MD, Benedetta Mazzi, BS, Jacopo Peccatori, MD, Silvano Rossini, MD, Maria G. Roncarolo, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Katharina Fleischhauer, MD

Blood (2006) 108 (11): 3223.

https://doi.org/10.1182/blood.V108.11.3223.3223

Published: 2006

NARROW

Targeted Therapy in FLT3-ITD Positive Myeloid Sarcoma: Proof of Principle

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Treosulfan-Based Myeloablative Conditioning for Autologous Stem Cell Transplantation In Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: Data of Feasibility and Efficacy In 10 Patients.

Implementation of An Alternative Donor Option Is Prerequisite for a Good Intention-to-Treat (ITT) In Patients In Need of Allogeneic Transplantation: Analysis of 410 Patients

Effect of Related and Unrelated Donor Haemopoietic Stem-Cell Transplantation on Outcome In Adults with High Risk Acute Leukemia: An Intention-to-Treat Analysis at a Single Center Institution

Allogeneic Transplantation with a Treosulfan-Fludarabine Conditioning Regimen Is Feasible and Effective in Elderly Patients with Refractory or Relapsed Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS); Preliminary Results From a Single Center Experience.

WT1 Transcripts Is a Powerful Leukemia Marker to Predict Early Relapse After Allogeneic Haematopoietic Stem Cell Transplantation.

Quantitative Real-Time PCR Detection of Wilms' Tumor Gene (WT1) Transcript in Autologous Peripheral Blood Stem Cell (PBSC) Products Predict the Risk of Acute Myeloid Leukaemia (AML) Relapse After Autologous Transplantation (ASCT).

Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors.

Genomic Loss of the Mismatched HLA Locus in Leukemia Is a Major Mechanism of in Vivo Escape from T Cell Immunosurveillance Following Haploidentical HSCT

Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation

Temporal, Quantitative and Functional Characteristics of Single-KIR Positive Alloreactive NK Cell Recovery Account for Impaired Graft Versus Leukemia Activity after Haploidentical HSCT.

Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only